YRDC expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.85180001835528E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.78699999997534E-06 |
Normal-vs-Stage2 |
2.78639999995445E-06 |
Normal-vs-Stage3 |
4.15529999298059E-09 |
Normal-vs-Stage4 |
8.25109999991192E-07 |
Stage1-vs-Stage2 |
2.267800E-01 |
Stage1-vs-Stage3 |
3.930400E-02 |
Stage1-vs-Stage4 |
2.470600E-01 |
Stage2-vs-Stage3 |
7.505000E-01 |
Stage2-vs-Stage4 |
8.271000E-01 |
Stage3-vs-Stage4 |
5.334000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.86460002993272E-09 |
Normal-vs-AfricanAmerican |
6.437800E-04 |
Normal-vs-Asian |
4.768200E-02 |
Caucasian-vs-AfricanAmerican |
9.254200E-01 |
Caucasian-vs-Asian |
8.148600E-01 |
AfricanAmerican-vs-Asian |
8.700200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.00732788566438E-12 |
Normal-vs-Female |
2.400700E-03 |
Male-vs-Female |
2.34550000000056E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.89549999999717E-05 |
Normal-vs-Age(41-60Yrs) |
1.37989997206489E-09 |
Normal-vs-Age(61-80Yrs) |
6.47549999954755E-07 |
Normal-vs-Age(81-100Yrs) |
4.043900E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.805800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.998600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.490600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.386030E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.317600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.946400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.701600E-01 |
Normal-vs-Grade 2 |
1.227940E-04 |
Normal-vs-Grade 3 |
1.38430378271437E-11 |
Normal-vs-Grade 4 |
4.57530000552708E-08 |
Grade 1-vs-Grade 2 |
5.629000E-01 |
Grade 1-vs-Grade 3 |
1.708190E-01 |
Grade 1-vs-Grade 4 |
1.953840E-01 |
Grade 2-vs-Grade 3 |
2.186800E-04 |
Grade 2-vs-Grade 4 |
1.256500E-02 |
Grade 3-vs-Grade 4 |
8.600000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.544280E-03 |
Normal-vs-ccB subtype |
8.41404723672667E-12 |
ccA subtype-vs-ccB subtype |
9.72609999982943E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.06739999564221E-08 |
Normal-vs-N1 |
8.172800E-04 |
N0-vs-N1 |
6.684200E-01 |
|
|